Cuvposa (glycopyrrolate) is an anticholinergic used to treat excessive drooling in children with certain conditions affecting the brain, such as cerebral palsy. The dosage that each child needs can vary. It comes as an oral solution and is available both as a brand-name and generic medications. Side effects include dry mouth, constipation, and sweating less.
Cuvposa (glycopyrrolate) is an anticholinergic. It blocks a chemical called acetylcholine on salivary glands, where saliva is made and released into the mouth. While saliva can help with swallowing and chewing, too much can cause drooling. This is often seen in conditions that affect the brain, such as cerebral palsy.
Cuvposa (glycopyrrolate) helps manage this by lowering the amount of saliva that's made.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):
Probably not. In clinical studies, weight gain was not listed as a side effect for those taking Cuvposa (glycopyrrolate). If your child is gaining weight after taking this medication, talk to their pediatrician.
It takes 12 to 15 hours for most of Cuvposa (glycopyrrolate) to leave your body after a single dose. This time frame is estimated based on the half-life of Cuvposa (glycopyrrolate).
Although it does take about 3 hours for the body to fully absorb Cuvposa (glycopyrrolate), how long it lasts depends on many things. But what's important is that for the medication to work well, your child will need to take it 3 times a day. Talk to your child's pediatrician if you have questions about this medication.
In clinical studies, Cuvposa (glycopyrrolate) started working to reduce drooling in children as early as 4 weeks. Keep in mind that everyone is different. In some instances, it might take at least 8 weeks for it to work fully. Discuss with your child's pediatrician about how long this medication is expected to work for your child.
Probably not. Hair loss wasn't reported as a side effect in clinical studies of people taking Cuvposa (glycopyrrolate). If your child is experiencing hair loss after taking this medication, let their pediatrician know.
Yes. Cuvposa (glycopyrrolate) belongs to a class of medications called anticholinergics.
Cuvposa (glycopyrrolate) has only been studied in children ages 3 to 16. Because there aren't any studies in children under age 3, discuss the risks and benefits of using Cuvposa (glycopyrrolate) with your child's pediatrician.
Although they contain the same active ingredient (glycopyrrolate) they are approved for different uses. Cuvposa (glycopyrrolate) is an oral solution used to treat excessive drooling in children ages 3 to 16 with certain conditions that affect the brain. Robinul (glycopyrrolate) is a tablet used as an add-on treatment for stomach ulcers and can't be used in children under the age of 12. Cuvposa (glycopyrrolate) and glycopyrrolate (Robinul) can't be substituted for each other because they are available in different dosage forms and contain different amounts of glycopyrrolate.
Cuvposa (glycopyrrolate) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Constipation is a common side effect of Cuvposa (glycopyrrolate), especially within the first 4 to 5 days of starting the medication and after a dose is raised. If your child complains of constipation, stomach pain, swelling, nausea, and vomiting, stop Cuvposa (glycopyrrolate) and tell their pediatrician because this could be a sign of intestinal pseudo-obstruction (a rare condition that prevents your intestinal muscles from moving).
Cuvposa (glycopyrrolate) can cause blockage in the intestine. Diarrhea can be an early sign of this blockage, especially if your child has a history of surgical procedures in the intestines, like an ileostomy or colostomy. If your child has diarrhea, stop Cuvposa (glycopyrrolate) and let their pediatrician know.
Cuvposa (glycopyrrolate) can cause your child to sweat less, which can lead to fever or heat strokes in hot weather. To avoid overheating, have your child cool down and rest in the shade, drink cold water, and take breaks while running around or playing. Call their pediatrician right away if your child becomes sick, less alert, passes out, or has any other symptoms of heatstroke, such as hot and red skin, fast heartbeat, difficulty breathing, or fever.
Cuvposa (glycopyrrolate) can cause sleepiness or blurred vision. Don’t let your child do any activities that require concentration until you know how Cuvposa (glycopyrrolate) affects your child.
Some health conditions can worsen if your child takes Cuvposa (glycopyrrolate). For example, if your child has heart problems, be careful when giving this medication because it can raise their heart rate.
If your child has an inflamed colon (ulcerative colitis), higher doses of Cuvposa (glycopyrrolate) can slow their stomach and intestinal muscles, which can lead to life-threatening conditions of the intestine. Talk to their pediatrician if you’re concerned about certain worsening conditions for your child.
| Dosage | Quantity | Price as low as | Price per unit |
|---|---|---|---|
| 473ml of 1mg/5ml | 1 bottle | $70.84 | $70.84 |
The dosing is based on your child's weight.
The typical starting dose is 0.02 mg/kg by mouth three times daily. Your child's pediatrician will slowly raise the dose every 5 to 7 days, depending on how well the medication is working and if your child experiences side effects.
The maximum dose is 0.1 mg/kg three times daily, with no doses greater than 1.5 to 3 mg per dose based on weight.
Contraindications are specific health conditions or situations in which a person should not take a medication due to safety concerns. If you have any of the following conditions or if any of the following apply to you, let your healthcare provider know because Cuvposa (glycopyrrolate) will not be safe for you to take.